Safety and tolerability of fentanyl sublingual spray during the titration phase of two phase 3 clinical trials: results from pooled data

被引:0
|
作者
Rauck, R. [1 ]
Stearns, L. [1 ]
Forman, N. [1 ]
Parikh, N. [1 ]
Dillaha, L. [1 ]
机构
[1] INSYS Therapeut, Chandler, AZ USA
来源
JOURNAL OF PAIN | 2014年 / 15卷 / 04期
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
365
引用
收藏
页码:S67 / S67
页数:1
相关论文
共 50 条
  • [21] Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
    Sticherling, Michael
    Nikkels, Arjen F.
    Hamza, Ashraf M.
    Kwong, Pearl
    Szepietowski, Jacek C.
    El Sayed, Mahira
    Ghislain, Pierre-Dominique
    Khotko, Alkes A.
    Patekar, Manmath
    Ortmann, Christine-Elke
    Forrer, Pascal
    Papanastasiou, Philemon
    Keefe, Deborah
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 821 - 835
  • [22] Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
    Michael Sticherling
    Arjen F. Nikkels
    Ashraf M. Hamza
    Pearl Kwong
    Jacek C. Szepietowski
    Mahira El Sayed
    Pierre-Dominique Ghislain
    Alkes A. Khotko
    Manmath Patekar
    Christine-Elke Ortmann
    Pascal Forrer
    Philemon Papanastasiou
    Deborah Keefe
    American Journal of Clinical Dermatology, 2023, 24 : 821 - 835
  • [23] Safety and tolerability of atogepant: A post hoc analysis of pooled data from four clinical trials
    Rizzoli, P.
    Marmura, M. J.
    Robblee, J.
    McVige, J. W.
    Sacco, S. E.
    Ferreira, R.
    Rekeda, L.
    Ma, J.
    Dabruzzo, B. L.
    Ashina, M.
    HEADACHE, 2022, 62 : 121 - 122
  • [24] Crisaborole ointment improves global atopic dermatitis severity: Pooled results from two phase 3 clinical trials
    Fowler, J. F.
    Sidbury, B.
    Zaenglein, A. L.
    Pariser, D. M.
    Cook-Bolden, F. E.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 66 - 66
  • [25] Crisaborole ointment improves global atopic dermatitis severity: Pooled results from two phase 3 clinical trials
    Fowler, J.
    Sidbury, R.
    Zaenglein, A. L.
    Pariser, D. M.
    Cook-Bolden, F. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S193 - S193
  • [26] Safety and tolerability of atogepant: a post hoc analysis of pooled data from four clinical trials
    Rizzoli, P.
    Marmura, M.
    Robblee, J.
    McVige, J.
    Sacco, S.
    Ferreira, R. De Abreu
    Rekeda, L.
    Ma, J.
    Dabruzzo, B.
    Ashina, M.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [27] Crisaborole ointment improves global atopic dermatitis severity: Pooled results from two phase 3 clinical trials
    Fowler, Joseph
    Sidbury, Robert
    Zaenglein, Andrea
    Pariser, David
    Cook-Bolden, Fran
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB86 - AB86
  • [28] Safety and Tolerability of Rufinamide in Pediatric Patients: Pooled Data from the Rufinamide Clinical Trials in Epilepsy
    Wheless, J.
    Conry, J.
    Krauss, G.
    Mann, A.
    LoPresti-Solis, A.
    Narurkar, M.
    ANNALS OF NEUROLOGY, 2009, 66 : S126 - S126
  • [29] Pooled Safety Results from Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis Through 1 Year
    Ritchlin, Christopher
    Rahman, Proton
    Helliwell, Philip
    Boehncke, Wolf-Henning
    McInnes, Iain
    Gottlieb, Alice
    Kafka, Shelly
    Kollmeier, Alexa
    Hsia, Elizabeth
    Xu, Xie
    Shawi, May
    Sheng, Shihong
    Agarwal, Prasheen
    Zhou, Bei
    Ramachandran, Paraneedharan
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [30] POOLED SAFETY RESULTS FROM TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 1 YEAR
    Ritchlin, C. T.
    Rahman, P.
    Helliwell, P.
    Boehncke, W. H.
    Mcinnes, I.
    Gottlieb, A. B.
    Kafka, S.
    Kollmeier, A.
    Hsia, E. C.
    Xu, X. L.
    Shawi, M.
    Sheng, S.
    Agarwal, P.
    Zhou, B.
    Ramachandran, P.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1300 - 1301